Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 janv. 2024 08h01 HE | Source: Research and Markets

DSUVIA (sufentanil) Drug Insights and U.S. Market Analysis, 2023-2032

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DSUVIA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This extensive report...
29 janv. 2024 12h15 HE | Source: Research and Markets

MAXIGESIC IV Drug Insight and U.S. Market Forecasts to 2032: In-depth Product Overview, Regulatory Milestones, Competitive Landscape Analysis, and SWOT Analysis

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Dual Mode-of-Action...
29 janv. 2024 12h14 HE | Source: Research and Markets

ANJESO Drug Insight and Market Forecast in the United States, 2023-2032: Developmental Milestones, Intellectual Property Insights, Future Market Forecast, and SWOT Analysis with Sales Projections

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States ANJESO Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
24 janv. 2024 07h43 HE | Source: Research and Markets

United States OLINVYK Drug Insight and Market Forecasts, 2019-2032: A Novel G Protein-biased (selective) Mu-opioid Receptor (MOR) Ligand Approved to Manage Acute Pain

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "United States OLINVYK Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...